SPX and Nasdaq hit new highs
Expectations that two Covid-19 vaccines could get emergency FDA approval, which would make up to 40 million doses available before the end of the year, had investors in a risk-on…
Read MoreExpectations that two Covid-19 vaccines could get emergency FDA approval, which would make up to 40 million doses available before the end of the year, had investors in a risk-on…
Read MoreThe Institute for Supply Management (ISM) reported its manufacturing index cooled to 57.5 for November
Read MoreThe environment is likely to stay volatile in both directions over coming days/weeks as we await the Georgia Senate runoff election. The S&P 500 (SPX) is very little changed from…
Read More